Medidata and InterMune Work Together to Integrate Clinical and Safety Databases
InterMune, a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases, decided several years ago to begin using electronic data capture (EDC) for future clinical studies.
In addition to looking for an EDC solution that would streamline its clinical research process and enable real-time access to clinical data, InterMune also wanted a system that could integrate with its safety database to reduce reconciliation of serious adverse event (SAE) data between clinical and safety databases, and eliminate time-consuming and redundant data entry to the drug safety database.
With Rave Safety Gateway, InterMune now has the ability to ensure specific safety process needs are met through comprehensive business rules, which are independently designed to govern parameters specific to a trial’s design.
With Rave Safety Gateway, InterMune now has the ability to ensure specific safety process needs are met through comprehensive business rules